NCT02843581View on ClinicalTrials.gov

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2019

Conditions
Metastatic Esophageal Cancer
Interventions
DEVICE

Cryosurgery

Argon-helium cryosurgical system

BIOLOGICAL

NK immunotherapy

Nutral killer cell immunotherapy for more than 6 times

Trial Locations (1)

510000

Fuda cancer institute in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Shenzhen Hank Bioengineering Institute

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02843581 - Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter